Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Language
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Targeted Therapy Against All T...
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Permanent link
Targeted Therapy Against All Three VEGF Receptors by Cediranib Enhances the Antitumor and Anti-metastatic Effects of Paclitaxel and Radiation in an Orthotopic Human Lung Cancer Model
Bibliographic Details
Main Authors:
Takahashi, O
,
Komaki, R
,
Tailor, R
,
Juergensmeier, J
,
Ryan, A
,
Smith, P
,
Jacoby, J
,
Korshunova, M
,
Herbst, R
,
O'Reilly, MS
Format:
Journal article
Published:
2010
Holdings
Description
Similar Items
Staff View
Similar Items
MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib
by: Takahashi, O, et al.
Published: (2009)
Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis
by: Takahashi, O, et al.
Published: (2012)
Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
by: Takahashi, O, et al.
Published: (2012)
Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma.
by: Medinger, M, et al.
Published: (2009)
The effect of food on the single dose pharmacokinetics of cediranib
by: Jayson, G, et al.
Published: (2008)